|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 374.15 USD | +3.55% |
|
+4.41% | +14.31% |
| Jul. 02 | Amgen Wins Preliminary Injunction to Block Colorado From Imposing Price Cap on Arthritis Drug | MT |
| Jul. 02 | Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial | DJ |
| Market Cap | 202B 177B 162B 151B 287B 19,224B 291B 1,947B 757B 9,441B 758B 742B 32,579B | P/E 2026 * |
24.4x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 244B 213B 196B 183B 346B 23,194B 351B 2,350B 913B 11,391B 915B 895B 39,308B | EV / Sales 2026 * |
6.45x | EV / Sales 2027 * | 6.15x |
| Free-Float |
99.78% | Yield 2026 * |
2.7% | Yield 2027 * | 2.85% |
Last Transcript: Amgen Inc.
| 1 day | +3.55% | ||
| 1 week | +4.41% | ||
| Current month | +3.32% | ||
| 1 month | +10.62% | ||
| 3 months | +7.53% | ||
| 6 months | +14.20% | ||
| Current year | +14.31% |
| 1 week | 356.87 |  | 375.15 |
| 1 month | 334.05 | | 375.15 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.44 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
| Director of Finance/CFO | 62 | 2010-05-12 | |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.55% | +4.41% | +25.45% | +66.28% | 202B | |
| +1.86% | +0.48% | +55.50% | +163.08% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.03% | 633B | |
| +3.99% | +3.05% | +37.93% | +93.37% | 461B | |
| +3.86% | +1.64% | +32.57% | +24.89% | 338B | |
| -0.56% | +0.96% | +41.67% | +39.35% | 299B | |
| -0.08% | +1.30% | +32.15% | +44.48% | 291B | |
| -1.54% | +2.81% | -25.35% | -39.61% | 222B | |
| +4.21% | +2.65% | +17.47% | +71.11% | 163B | |
| +1.84% | +0.12% | -4.18% | -33.64% | 139B | |
| Average | +2.07% | +4.40% | +28.18% | +49.03% | 383.1B | |
| Weighted average by Cap. | +2.23% | +5.43% | +40.63% | +79.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.76B 33.03B 30.31B 28.3B 53.61B 3,595B 54.41B 364B 142B 1,765B 142B 139B 6,092B | 38.71B 33.86B 31.08B 29.01B 54.97B 3,686B 55.78B 373B 145B 1,810B 145B 142B 6,246B |
| Net income | 8.23B 7.2B 6.61B 6.17B 11.69B 784B 11.86B 79.39B 30.86B 385B 30.91B 30.23B 1,328B | 8.86B 7.75B 7.12B 6.64B 12.59B 844B 12.77B 85.49B 33.23B 414B 33.28B 32.56B 1,430B |
| Net Debt | 41.7B 36.47B 33.48B 31.25B 59.21B 3,970B 60.09B 402B 156B 1,950B 157B 153B 6,729B | 36.06B 31.54B 28.94B 27.02B 51.19B 3,433B 51.96B 348B 135B 1,686B 135B 132B 5,817B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | $374.15 | +3.55% | 2,487,837 |
| 26-07-01 | $361.33 | -0.22% | 2,244,791 |
| 26-06-30 | $362.12 | +0.44% | 2,246,908 |
| 26-06-29 | $360.55 | +0.62% | 2,461,887 |
| 26-06-26 | $358.33 | +1.56% | 3,610,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
